Dr. Alejandro R. Calvo, MD

Dr. Calvo practices at Kettering Health Dayton in Dayton, Ohio, part of Kettering Adventist Healthcare.

Dr. Calvo's NPI, 1457341760, was assigned on October 27, 2005. Dr. Calvo graduated from Universidad Mayor de San Simon Faculty of Health Sciences in 1992. Dr. Calvo holds Ohio license 35-07-0077.

Dr. Calvo's primary practice is Kettering Health Dayton, at 405 Grand Avenue, Dayton, OH 45405 in Montgomery County. The practice phone is (937) 723-3410.

Dr. Calvo's primary practice is Kettering Health Dayton in Dayton, Ohio, part of Kettering Adventist Healthcare. Dr. Calvo is also affiliated with Kettering Health Main Campus. The medical group on file is Kettering Health Medical Group. Dmand AI also links Dr. Calvo to 3 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Calvo practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Calvo's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Calvo is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Calvo's licenses on file in 3 states: Ohio, Pennsylvania and Iowa.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Calvo treats.

CMS data shows 1,546 Medicare services from Dr. Calvo across 6 procedure codes in 2024, for 432 Medicare patients. Medicare paid $96,577 for them.

CMS counts 432 Medicare patients who saw Dr. Calvo in 2024. The largest group is 65 to 74, with 213 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Calvo's median patient age at 69, with 58% women.

In 2024, Dr. Calvo wrote 2,442 Medicare Part D claims for 364 patients. 74% of them were for generic drugs. CMS names the drug for 2,087 of them, across 44 drugs with 11 or more claims each, at $5,551,681 in total drug cost. In 2023, CMS named 1,708 claims across 47 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Calvo for performance year 2024, reported as part of a group. Dr. Calvo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 24 papers to Dr. Calvo, published from 2010 to 2024. 2016 was the busiest year, with 3. Dr. Calvo has published most often in World J Oncol. Dr. Calvo's most frequent co-authors are Lex Philip Leonhardt, DO, Giuseppe Giaccone and Jacqueline C. Barrientos, MD.

Dmand AI links Dr. Calvo to 3 clinical trials. 3 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Neoplasm Metastasis. Mirati Therapeutics Inc. sponsors the most, 2.

CMS Open Payments shows 646 general payments to Dr. Calvo from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 81% of the total. AstraZeneca Pharmaceuticals LP paid the most, $183,948.

Dmand AI lists 13 awards for Dr. Calvo, most recently VITALS Compassionate Doctor Award in 2014.

Dr. Calvo graduated from Universidad Mayor de San Simon Faculty of Health Sciences in 1992. Dr. Calvo is a member of ACP, ASCO, ASH and International Association for the Study of Lung Cancer (IASLC).

Dr. Calvo is in network with 18 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.